Nur Ink Innovations Ltd (TLV:NURI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
783.80
-13.30 (-1.67%)
Apr 20, 2026, 5:24 PM IDT

Nur Ink Innovations Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.330.25---
Revenue Growth (YoY)
29.25%----
Cost of Revenue
1.721.30.060.080.14
Gross Profit
-1.4-1.04-0.06-0.08-0.14
Selling, General & Admin
3.894.083.684.964.08
Research & Development
3.524.448.776.453.07
Amortization of Goodwill & Intangibles
--0.59--
Operating Expenses
7.418.5313.0411.417.15
Operating Income
-8.81-9.57-13.1-11.5-7.29
Interest Expense
-0.41-0.38-0.37-0.38-0.48
Interest & Investment Income
0.020.250.540.2-
Currency Exchange Gain (Loss)
-0.01-0.010.030.08-
Other Non Operating Income (Expenses)
-0.21-0.04-0.02-0.02-
EBT Excluding Unusual Items
-9.42-9.74-12.92-11.61-7.77
Gain (Loss) on Sale of Assets
-----0.01
Pretax Income
-9.42-9.74-12.92-11.61-7.78
Net Income
-9.42-9.74-12.92-11.61-7.78
Net Income to Common
-9.42-9.74-12.92-11.61-7.78
Shares Outstanding (Basic)
76654
Shares Outstanding (Diluted)
76654
Shares Change (YoY)
10.92%8.22%8.80%17.73%34.29%
EPS (Basic)
-1.42-1.63-2.34-2.29-1.81
EPS (Diluted)
-1.42-1.63-2.34-2.29-1.81
Free Cash Flow
-7.87-7.49-9.48-8.09-9.12
Free Cash Flow Per Share
-1.19-1.25-1.72-1.59-2.12
Operating Margin
-2692.97%-3781.82%---
Profit Margin
-2879.51%-3849.41%---
Free Cash Flow Margin
-2407.03%-2960.87%---
EBITDA
-8.11-8.97-11.37-10.47-6.62
D&A For EBITDA
0.690.61.731.030.67
EBIT
-8.81-9.57-13.1-11.5-7.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.